Total planned funding: $294,788,775
Allocations
Countries/Regions
| Eswatini | $294,788,775 |
Organizational Types
| Private Contractor | $71,825,197 |
| Unknown | $68,588,400 |
| NGO | $48,243,359 |
| University | $40,692,712 |
| Own Agency | $38,605,521 |
| Multi-lateral Agency | $8,535,854 |
| FBO | $7,784,055 |
| Host Country Government Agency | $6,795,230 |
| Other USG Agency | $3,668,447 |
| Implementing Agency | $50,000 |
Program Areas
| Care | $89,977,795 |
| Treatment | $75,314,719 |
| Prevention | $56,130,302 |
| Governance and Systems | $33,174,317 |
| Management and Operations | $21,753,364 |
| Testing | $18,438,278 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $59,563,125 |
| HBHC: Care: Adult Care and Support | $34,305,075 |
| HKID: Care: Orphans and Vulnerable Children | $31,253,009 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $25,255,075 |
| HVMS: Management and Operations | $21,753,364 |
| HVCT: Testing: HIV Testing and Counseling | $18,438,278 |
| HVSI: Strategic Information | $17,237,875 |
| HVTB: Care: TB/HIV | $15,801,546 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $15,257,380 |
| OHSS: Health Systems Strengthening | $11,225,666 |
| PDCS: Care: Pediatric Care and Support | $8,618,165 |
| HTXD: Treatment: ARV Drugs | $8,436,985 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $8,151,266 |
| PDTX: Treatment: Pediatric Treatment | $7,314,609 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,539,610 |
| HLAB: Laboratory Infrastructure | $4,710,776 |
| HMBL: Biomedical Prevention: Blood Safety | $926,971 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$54,527,520
Countries/Regions
Pact, Inc.:
$34,248,021
Countries/Regions
Columbia University:
$33,451,480
Countries/Regions
Chemonics International:
$16,923,647
Countries/Regions
USG Aggregated Agencies:
$16,119,283
Countries/Regions